ICON partners with Korean national clinical trials enterprise

Singapore: ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical ...

October 9, 2012 | Tuesday | News
New laser to deliver drugs painlessly

Singapore: A new type of drug delivery system has been devised, which uses an erbium-doped yttrium aluminium garnet lase...

September 17, 2012 | Monday | News
Which domain of clinical research do APAC CROs focus on?

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...

September 18, 2013 | Wednesday | Analysis
IVI appoints new board members

Singapore: South Korea-headquartered International Vaccine Institute (IVI) has appointed Professor Fred Binka, Dr Josep...

November 20, 2013 | Wednesday | Influencers
Foot and Mouth disease outbreak in South Korea

fsdfs...

April 24, 2014 | Thursday | News
Celltrion files for Remsima approval in Japan

Singapore: Korea-based Celltrion has completed filing procedure of biosimilar drug Remsima to obtain Japan's Ministry of...

September 17, 2013 | Tuesday | News
South Korean drug firms look overseas for profit

Singapore: In a bid to generate new profit engines, South Korean pharmaceutical companies have set their eyes on oversea...

August 5, 2013 | Monday | News
SNUH integrates OmniComm solutions for clinical trial data

Singapore: OmniComm Systems, a provider of clinical data management solutions for clinical trials, has signed a five yea...

April 4, 2014 | Friday | News
Pfizer trial of cancer drug INLYTA is a failure

Singapore: Pfizer has revealed that its phase III study of INLYTA (axitinib) did not meet the primary endpoint of demons...

October 22, 2012 | Monday | News
Korea to improvise Jordan healthcare system

Singapore: Korean International Cooperation Agency (KOICA) signed a memorandum of understanding with the Ministry of Hea...

July 7, 2014 | Monday | News
Malaysian firm Duopharma forays into biosimilars

Singapore: Malaysia's chemical company Duopharma has tied up with Korea's PanGen Biotech to pioneer a clinical trial of ...

August 1, 2012 | Wednesday | News
AstraZeneca, KHIDI setup cancer research program

Singapore: AstraZeneca signed a memorandum of understanding (MoU) with the Korea Health Industry Development Institute (...

March 11, 2014 | Tuesday | News
US biosimilars market to be $9 bn by 2020

Singapore: A new report by global business intelligence firm GBI Research has highlighted that the massive potential for...

October 3, 2012 | Wednesday | News
Will RNL stem cell drug trial get Korean FDA nod?

Singapore: RNL Bio filed an Investigational New Drug (IND) application with the Korean Food and Drug Administration (KFD...

February 12, 2013 | Tuesday | Regulatory
Samsung to make Roche biologics at Korean plant

Singapore: Samsung BioLogics and Roche have entered into a long term strategic manufacturing agreement under which Samsu...

October 24, 2013 | Thursday | News
RNL to license stem cell technology to in Turkey

Singapore: RNL Bio has signed the agreement with RST Biomedikal Sanayi, a Turkish company, to license RNL Bio's stem ce...

September 14, 2012 | Friday | News
Stem cells can help prevent Alzheimer's disease

Singapore: In the first study of its kind, researchers at one of Korea's leading university and the RNL Bio Stem Cell Te...

September 27, 2012 | Thursday | News
F&S: Medical devices market highly fragmented

Singapore: A new analysis from Frost & Sullivan, titled Medical Devices Distributor Profiling in Vietnam, Indonesia,...

December 11, 2012 | Tuesday | News